Wiley Matthew T.

Insider profile

Wiley Matthew T.'s trades of Definium Therapeutics Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-06-26 2026-06-25 PlS Planned sale
94,717 +19.2%
40.51
US$4,187,416
94,717 +19.2% 40.51 US$4,187,416
2026-06-25 2026-06-25 PrS Proposed sale
94,605
261.38
US$2,357,592
94,605 261.38 US$2,357,592
2024-10-03 2024-10-03 PrS Proposed sale
10,557
217.01
US$1,426,654
10,557 217.01 US$1,426,654
2024-10-03 2024-10-03 PlS Planned sale
6,272 -24.8%
0.55
US$3,450
6,272 -24.8% 0.55 US$3,450
2024-09-17 2024-09-16 PlS Planned sale
215 -5.1%
0.69
US$149
215 -5.1% 0.69 US$149
2024-09-16 2024-09-16 PrS Proposed sale
215
0.69
US$149
215 0.69 US$149
2024-06-18 2024-06-17 PlS Planned sale
244 -6.5%
1.26
US$308
244 -6.5% 1.26 US$308
2024-06-17 2024-06-17 PrS Proposed sale
244
1.26
US$308
244 1.26 US$308
2024-04-08 2024-04-04 PlS Planned sale
1,008 -25.2%
2.64
US$2,656
1,008 -25.2% 2.64 US$2,656
2024-04-04 2024-04-04 PrS Proposed sale
1,008
2.63
US$2,651
1,008 2.63 US$2,651
2019-03-06 2019-03-05 B Purchase
13,440 +26.9%
3.76
US$50,534
13,440 +26.9% 3.76 US$50,534